This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n11http://linked.opendata.cz/resource/drugbank/drug/DB08131/identifier/pubchem-compound/
dctermshttp://purl.org/dc/terms/
n9http://linked.opendata.cz/resource/drugbank/drug/DB08131/identifier/pubchem-substance/
n13http://linked.opendata.cz/resource/drugbank/drug/DB08131/identifier/drugbank/
n7http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n12http://linked.opendata.cz/resource/drugbank/drug/DB08131/identifier/chemspider/
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n10http://linked.opendata.cz/resource/drugbank/drug/DB08131/identifier/pdb/

Statements

Subject Item
n2:DB08131
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n7:DB08131 n14:DB08131
dcterms:title
2-{4-[2-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYLAMINO}-3-METHYL-BUTYRIC ACID
adms:identifier
n9:99444602 n10:LYD n11:446560 n12:393882 n13:DB08131
n3:IUPAC-Name
n4:271B6133-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B6139-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B6138-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B6135-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B6136-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B6137-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B6131-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B612F-363D-11E5-9242-09173F13E4C5 n4:271B6132-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B6130-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B613F-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B6140-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B613A-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B613B-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B613D-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B613C-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B613E-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B6145-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B6147-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B6148-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B6144-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B6143-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B6146-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B6134-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B6141-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B6142-363D-11E5-9242-09173F13E4C5